136 related articles for article (PubMed ID: 27109821)
21. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease.
Katsura H; Yamada K; Wakabayashi R; Kida K
Respirology; 2007 May; 12(3):427-32. PubMed ID: 17539850
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
[TBL] [Abstract][Full Text] [Related]
23. Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.
Houben-Wilke S; Spruit MA; Uszko-Lencer NHMK; Otkinska G; Vanfleteren LEGW; Jones PW; Wouters EFM; Franssen FME
Respirology; 2017 Jul; 22(5):928-934. PubMed ID: 28001000
[TBL] [Abstract][Full Text] [Related]
24. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.
Jones PW; Adamek L; Nadeau G; Banik N
Eur Respir J; 2013 Sep; 42(3):647-54. PubMed ID: 23258783
[TBL] [Abstract][Full Text] [Related]
25. Interpretation of quality of life scores from the St George's Respiratory Questionnaire.
Ferrer M; Villasante C; Alonso J; Sobradillo V; Gabriel R; Vilagut G; Masa JF; Viejo JL; Jiménez-Ruiz CA; Miravitlles M
Eur Respir J; 2002 Mar; 19(3):405-13. PubMed ID: 11936515
[TBL] [Abstract][Full Text] [Related]
26. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
27. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.
Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R
NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373
[TBL] [Abstract][Full Text] [Related]
28. Impact of comorbidities on COPD-specific health-related quality of life.
Burgel PR; Escamilla R; Perez T; Carré P; Caillaud D; Chanez P; Pinet C; Jebrak G; Brinchault G; Court-Fortune I; Paillasseur JL; Roche N;
Respir Med; 2013 Feb; 107(2):233-41. PubMed ID: 23098687
[TBL] [Abstract][Full Text] [Related]
29. The responsiveness of the Manchester Chronic Obstructive Pulmonary Disease Fatigue Scale to pulmonary rehabilitation.
Yohannes AM; Dryden S; Hanania NA
Ther Adv Chronic Dis; 2019; 10():2040622319882206. PubMed ID: 31695862
[TBL] [Abstract][Full Text] [Related]
30. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.
Foglio K; Bianchi L; Bruletti G; Porta R; Vitacca M; Balbi B; Ambrosino N
Respir Med; 2007 Sep; 101(9):1961-70. PubMed ID: 17531455
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of computed tomographic lung volumes in patients with chronic obstructive pulmonary disease.
Lee JS; Lee SM; Seo JB; Lee SW; Huh JW; Oh YM; Lee SD
Respiration; 2014; 87(3):196-203. PubMed ID: 24334816
[TBL] [Abstract][Full Text] [Related]
32. Peripheral muscle composition and health status in patients with COPD.
Montes de Oca M; Torres SH; Gonzalez Y; Romero E; Hernández N; Mata A; Tálamo C
Respir Med; 2006 Oct; 100(10):1800-6. PubMed ID: 16545558
[TBL] [Abstract][Full Text] [Related]
33. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease.
Schlecht NF; Schwartzman K; Bourbeau J
Chron Respir Dis; 2005; 2(4):183-91. PubMed ID: 16541601
[TBL] [Abstract][Full Text] [Related]
34. Behavior of Quality of Life (SGRQ) in COPD Patients According to BODE Scores.
Nonato NL; Díaz O; Nascimento OA; Dreyse J; Jardim JR; Lisboa C
Arch Bronconeumol; 2015 Jul; 51(7):315-21. PubMed ID: 25622995
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary function change in patients with Sauropus androgynus-related obstructive lung disease 15 years later.
Ou CY; Chen CZ; Lee CH; Lin CC; Chang HY; Hsiue TR
J Formos Med Assoc; 2013 Oct; 112(10):630-4. PubMed ID: 24120153
[TBL] [Abstract][Full Text] [Related]
36. Determinants of health-related quality of life worsening in patients with chronic obstructive pulmonary disease at one year.
Liang L; Lin Y; Yang T; Zhang H; Li J; Wang C
Chin Med J (Engl); 2014; 127(1):4-10. PubMed ID: 24384416
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.
Lin CW; Chen YY; Chen YJ; Liang CY; Lin MS; Chen W
Int J Chron Obstruct Pulmon Dis; 2015; 10():1493-500. PubMed ID: 26251589
[TBL] [Abstract][Full Text] [Related]
38. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
[TBL] [Abstract][Full Text] [Related]
39. Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease.
Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Pinet C; Roche N;
Respirology; 2014 Apr; 19(3):346-52. PubMed ID: 24330257
[TBL] [Abstract][Full Text] [Related]
40. Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates.
Bahmer T; Watz H; Waschki B; Gramm M; Magnussen H; Rabe KF; Wirtz H; Kirsten D; Kirsten A
Thorax; 2016 Jul; 71(7):662-3. PubMed ID: 26968971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
